Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
Effectiveness of an early cognitive-behavioral treatment in patients with work disability due to musculoskeletal disorders
Arthritis Care and Research , 07/07/09
Leon L et al. – Data provide evidence that early cognitive-behavioral treatment complementary to a rheumatologic care program for patients with recent-onset temporary work disability caused by musculoskeletal disorders (MSDs) is cost-effective, adds >20% efficacy to the rheumatologic care program, and reduces the duration of relapses.
Methods- An evaluation of whether an early cognitive-behavioral treatment complementary to a rheumatologic care program is effective
- Pts with work disability episode from 3-8 wks' duration were randomized into:
- Control group: rheumatologic care program or
- Intervention group: rheumatologic care program plus cognitive-behavioral treatment
- Enrollment lasted 24 mo and f/u lasted 6-24 mo
- Efficacy variables included:
- Duration of temporary work disability episodes
- Total number of work days saved
- Relative efficacy, and
- Relative rate to return to work
- An economic evaluation was also performed
- 181 pts (66 control and 115 intervention pts), generating 222 episodes of MSD-related temporary work disability
- Episodes were shorter in the intervention group vs control group, with a relative efficacy of 22.9%
- No differences in duration of first episode between groups, but relapse episodes were shorter in the intervention group
- Costs were also lower in the intervention group
- To save 1 day of temporary work disability, $13.50 had to be invested in the program
- Each dollar invested generated a benefit of $4.08
- The program had a net benefit of $172,607
Today in Other Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
Is Monotherapy as Good as Polypharmacy in Long-Term Treatment of Bipolar Disorder
Canadian Journal of Psychiatry, 11/16/09
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09
Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09
Today in Psychotherapy/analysis...keeping you current
Receive free subspecialty "5-minute updates" via email
The contribution of active medication to combined treatments of psychotherapy and pharmacotherapy for adult depression: a meta-analysis
Acta Psychiatrica Scandinavica, 11/23/09
Executive functions in children with Autism Spectrum Disorders
Brain and Cognition, 11/12/09
Medication and Parent Training in Children With Pervasive Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical Trial
Journal of the American Academy of Child and Adolescent Psychiatry, 11/09/09
Sponsor
Article Search
Sponsor


See Latest Articles


